Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 2, Issue 11, 2007, Pages 1022-1028

  Yendamuri, Sai ^a   Komaki, Ritsuko R ^a   Correa, Arlene M ^a   Allen, Pamela ^a   Wynn, Bob ^a   Blackmon, Shanda ^a   Hofstetter, Wayne L ^a   Rice, David C ^a   Roth, Jack A ^a   Swisher, Stephen G ^a   Vaporciyan, Ara A ^a   Walsh, Garrett L ^a   Mehran, Reza J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Lung cancer; Propensity scoring; Radiation therapy; Wedge resection

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; COST OF ILLNESS; FEMALE; HIGH RISK PATIENT; HUMAN; LOBECTOMY; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT CARE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; TREATMENT INDICATION; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

EID: 35848968206     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318158d4cb     Document Type: Article

References (18)

1. Howe HL, Wu X, Ries L, et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 2006;107:1711-1742.
2. Ginsberg RJ, Rubinstein L. The comparison of limited resection to lobectomy for T1N0 non-small cell lung cancer. LCSG 821. Chest 1994;106(6 Suppl):318S-319S.
3. Abratt RP, Morgan GW. Lung toxicity following chest irradiation in patients with lung cancer. Lung Cancer 2002;35:103-109.
4. Rubin D. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997;127:757-763.
5. Okada M, Koike T, Higashiyama M. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg 2006;132:769-775.
6. Fernando HC, Santos RS, Benfield JR, et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2005;129:261-267.
7. Mandrekar SJ, Schild SE, Hillman SL, et al. A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials. Cancer 2006;107:781-792.
8. Ohashi R, Takahashi K, Miura K, et al. Prognostic factors in patients with inoperable non-small cell lung cancer - an analysis of long-term survival patients. Gan To Kagaku Ryoho 2006;33:1595-1602.
9. Tsuchiya T, Akamine S, Muraoka M, et al. Stage IA non-small cell lung cancer: Vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy. Lung Cancer 2007;56:341-348.
10. Zierhut D, Bettscheider C, Schubert K, et al. Radiation therapy of stage I and II non-small cell lung cancer (NSCLC). Lung Cancer 2001;34(Suppl 3):S39-S43.
11. Fang LC, Komaki R, Allen P, et al. Comparison of outcomes for patients with medically inoperable stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:108-116.
12. Nyman J, Johansson KA, Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer - mature results for medically inoperable patients. Lung Cancer 2006;51:97-103.
13. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated sterotactic radiation therapy (hypoFXSRT) for stage I non small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007;2:94-100.
14. Chang JY, Zhang X, Wang X, et al. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006;65:1087-1096.
15. Fernando HC, De Hoyos A, Landreneau A, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2005;129:639-644.
16. D'Cunha J, Herndon JE, Herzan DL, et al. Poor correspondence between clinical and pathological staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial. Lung Cancer 2005;48:241-246.
17. Sarna L, Riedinger MS. Assessment of quality of life and symptom improvement in lung cancer clinical trials. Semin Oncol 2004;31:1-10.
18. Karmakar MK, Ho AM. Postthoracotomy pain syndrome. Thorac Surg Clin 2004;14:345-352.